Published trade mark details for 2597173
This information was published on 2025-11-03T07:42 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2597173 (IR 1881893) |
| (220) |
09 Sep 2025
|
| (300) |
US, 10 Mar 2025, 99075283
|
| (500) |
The mark consists of a design of multiple lines radiating outward, forming a symmetrical burst shape with an arrow pointing towards the center of the shape and the word "nextpoint" in a stylized font to the right of the shape.
|
| (511) (510) |
Class 1
Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use. Class 5 Pharmaceutical products for the treatment of cancer; antibodies for medical purposes. Class 42 Pharmaceutical products development; pharmaceutical research and development; research and development of medicines; research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immunotherapy and immuno-oncology; research and development in the field of immunotherapy and immuno-oncology. |
| (540) |
|
| (550) | Figurative |
| (730) |
NextPoint Therapeutics, Inc.
|
Find out more about publications on the About page.